Cargando…

Abbott ID now COVID-19 assay performance: a year in review

Detalles Bibliográficos
Autores principales:	Thwe, Phyu M., Maiyo, Elphas, Ren, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418095/ https://www.ncbi.nlm.nih.gov/pubmed/34634713 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115536

Ejemplares similares

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory
por: Thwe, Phyu M., et al.
Publicado: (2020)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test
por: Aupaix, Antoine, et al.
Publicado: (2021)

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)

Performance of Abbott ID‐Now rapid nucleic amplification test for laboratory identification of COVID‐19 in asymptomatic emergency department patients
por: Ramachandran, Anu, et al.
Publicado: (2021)

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19
por: Rhoads, Daniel D., et al.
Publicado: (2020)

Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
por: Srivastava, Smriti, et al.
Publicado: (2022)

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)

Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020)

The ID NOW COVID-19, a high-speed high-performance assay
por: Farfour, Eric, et al.
Publicado: (2021)

Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery
por: Babic, N., et al.
Publicado: (2023)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients
por: Murphy, Catherine, et al.
Publicado: (2021)

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
por: Bousquet, Aurore, et al.
Publicado: (2022)

Performance Evaluation of the Abbott Alinity hs Blood Slide Maker/Stainer
por: Kwak, Min-Sun, et al.
Publicado: (2022)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
por: Barnacle, J.R., et al.
Publicado: (2022)

Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective
por: Fan, Shu-Ling
Publicado: (2023)

Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
por: Deslandes, Vincent, et al.
Publicado: (2022)

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting
por: Graham, Maryza, et al.
Publicado: (2021)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Diagnostic performance and clinical application of preoperative COVID-19 bedside testing with ID NOW™
por: Tauh, Tonia, et al.
Publicado: (2021)

Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department
por: NguyenVan, Jean-Claude, et al.
Publicado: (2021)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

The laryngectomee guide for COVID-19 is now available in Portuguese
por: Brook, Itzhak, et al.
Publicado: (2021)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
por: Tosiano, Melissa A., et al.
Publicado: (2022)

Correction to: Diagnostic performance and clinical application of preoperative COVID-19 bedside testing with ID NOW™
por: Tauh, Tonia, et al.
Publicado: (2021)

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
por: Stokes, William, et al.
Publicado: (2023)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

Predicting COVID-19 incidence in Pakistan: It's time to act now!
por: Khan, Muhammad Imran, et al.
Publicado: (2022)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqno66c6ddaagjt3rc66vqunfk